Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.

Simonsen PE, Pedersen EM, Rwegoshora RT, Malecela MN, Derua YA, Magesa SM.

PLoS Negl Trop Dis. 2010 Jun 1;4(6):e696. doi: 10.1371/journal.pntd.0000696.

2.

Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission.

Simonsen PE, Derua YA, Kisinza WN, Magesa SM, Malecela MN, Pedersen EM.

BMC Infect Dis. 2013 Jul 21;13:335. doi: 10.1186/1471-2334-13-335.

3.

Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Jul 29;60(29):989-91.

4.

Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.

Endeshaw T, Taye A, Tadesse Z, Katabarwa MN, Shafi O, Seid T, Richards FO Jr.

Pathog Glob Health. 2015;109(7):344-51. doi: 10.1080/20477724.2015.1103501.

5.

Transmission indices and microfilariae prevalence in human population prior to mass drug administration with ivermectin and albendazole in the Gomoa District of Ghana.

Aboagye-Antwi F, Kwansa-Bentum B, Dadzie SK, Ahorlu CK, Appawu MA, Gyapong J, Wilson MD, Boakye DA.

Parasit Vectors. 2015 Oct 26;8:562. doi: 10.1186/s13071-015-1105-x.

6.

Monitoring lymphatic filariasis control in Tanzania: effect of repeated mass drug administration on circulating filarial antigen prevalence in young schoolchildren.

Simonsen PE, Magesa SM, Derua YA, Rwegoshora RT, Malecela MN, Pedersen EM.

Int Health. 2011 Sep;3(3):182-7. doi: 10.1016/j.inhe.2011.06.009.

PMID:
24038368
7.

The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.

Weil GJ, Kastens W, Susapu M, Laney SJ, Williams SA, King CL, Kazura JW, Bockarie MJ.

PLoS Negl Trop Dis. 2008;2(12):e344. doi: 10.1371/journal.pntd.0000344. Epub 2008 Dec 9.

8.

Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.

Richards FO, Eigege A, Miri ES, Kal A, Umaru J, Pam D, Rakers LJ, Sambo Y, Danboyi J, Ibrahim B, Adelamo SE, Ogah G, Goshit D, Oyenekan OK, Mathieu E, Withers PC, Saka YA, Jiya J, Hopkins DR.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1346. doi: 10.1371/journal.pntd.0001346. Epub 2011 Oct 11.

9.

First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.

Nana-Djeunga HC, Tchouakui M, Njitchouang GR, Tchatchueng-Mbougua JB, Nwane P, Domche A, Bopda J, Mbickmen-Tchana S, Akame J, Tarini A, Epée E, Biholong BD, Zhang Y, Tougoue JJ, Kabore A, Njiokou F, Kamgno J.

PLoS Negl Trop Dis. 2017 Jun 29;11(6):e0005633. doi: 10.1371/journal.pntd.0005633. eCollection 2017 Jun.

10.
11.

Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.

Wamae CN, Njenga SM, Ngugi BM, Mbui J, Njaanake HK.

Acta Trop. 2011 Sep;120 Suppl 1:S33-8. doi: 10.1016/j.actatropica.2010.09.009. Epub 2010 Oct 8.

12.

Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.

Evans DS, Alphonsus K, Umaru J, Eigege A, Miri E, Mafuyai H, Gonzales-Peralta C, Adamani W, Pede E, Umbugadu C, Saka Y, Okoeguale B, Richards FO.

PLoS Negl Trop Dis. 2014 Sep 18;8(9):e3113. doi: 10.1371/journal.pntd.0003113. eCollection 2014 Sep.

13.

Bancroftian filariasis: effect of repeated treatment with diethylcarbamazine and albendazole on microfilaraemia, antigenaemia and antifilarial antibodies.

Helmy H, Weil GJ, Ellethy AS, Ahmed ES, Setouhy ME, Ramzy RM.

Trans R Soc Trop Med Hyg. 2006 Jul;100(7):656-62. Epub 2006 Jan 18.

PMID:
16414095
15.

Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo.

Pion SDS, Chesnais CB, Weil GJ, Fischer PU, Missamou F, Boussinesq M.

Lancet Infect Dis. 2017 Jul;17(7):763-769. doi: 10.1016/S1473-3099(17)30175-5. Epub 2017 Mar 31.

PMID:
28372977
16.

Urban lymphatic filariasis in the city of Tanga, Tanzania, after seven rounds of mass drug administration.

Mwakitalu ME, Malecela MN, Pedersen EM, Mosha FW, Simonsen PE.

Acta Trop. 2013 Dec;128(3):692-700. doi: 10.1016/j.actatropica.2013.10.004. Epub 2013 Oct 14.

17.

Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration.

Simonsen PE, Derua YA, Magesa SM, Pedersen EM, Stensgaard AS, Malecela MN, Kisinza WN.

Parasit Vectors. 2014 Nov 12;7:507. doi: 10.1186/s13071-014-0507-5.

18.

Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochromatographic test in Malindi, Kenya.

Njenga SM, Wamae CN, Njomo DW, Mwandawiro CS, Molyneux DH.

Trans R Soc Trop Med Hyg. 2008 Oct;102(10):1017-24. doi: 10.1016/j.trstmh.2008.04.039. Epub 2008 Jun 11.

PMID:
18550135
19.

Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India.

Ramaiah KD, Vanamail P, Yuvaraj J, Das PK.

Trans R Soc Trop Med Hyg. 2011 Aug;105(8):431-7. doi: 10.1016/j.trstmh.2011.04.006. Epub 2011 May 23.

PMID:
21601901
20.

Supplemental Content

Support Center